Filing Details
- Accession Number:
- 0001209191-22-046613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-18 16:14:37
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-08-18 16:14:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1740279 | In8Bio Inc. | INAB | Biological Products, (No Disgnostic Substances) (2836) | 825462585 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1898521 | Kate Rochlin | C/O In8Bio, Inc. 350 5Th Ave. Suite 5330 New York NY 10118 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-16 | 5,263 | $1.90 | 5,263 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
